Shanghai Pharmaceuticals Group Co., Ltd. Board Member and Employee Diversity Policy
No.: Company-Director-020-2025-V2
Shanghai Pharmaceutical Group Co., Ltd.
Board Membership and Employee Diversity Policy
Article 1 Purpose
The purpose of this policy is to set out the principles that Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as the "Company" or the "Company") adheres to in order to maintain a diverse Board of Directors and a diverse workforce.
Article 2 Policy Statement
(1) In terms of board appointment and employee selection, the company has always implemented a diversity policy, which has been reflected in the current composition of the board of directors.
(2) Therefore, this policy aims to formalize the company's board member and employee diversity policy and comply with the requirements of Appendix C1 "Corporate Governance Code" of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
(3) The Company regards diversity as a broad concept and believes that in order to obtain diverse perspectives and perspectives, multiple factors can be considered, including (but not limited to) skills, regional and industry experience, background, race, gender and other characteristics. In terms of implementing diversification, the Company will also consider various factors based on its own business model and specific needs that keep pace with the times.
(4) The company is committed to creating a diverse, inclusive and supportive working environment to ensure that all employees (including senior management) are respected and treated equally and receive fair career development opportunities.
Article 3 Measurable goals and implementation
(1) When evaluating candidates for the Board of Directors, the Nominating Committee of the Board of Directors will consider the diverse perspectives described in this policy, including but not limited to gender, age, cultural and educational background, race, professional experience, skills, knowledge and length of service. Notwithstanding this, all directors will be appointed on a merit-based basis and, in addition to taking into account the benefits of diversity on the Board, decisions will ultimately be made based on the candidate's merits and overall contribution to the Board.
(2) The company will continue to strive to maintain an appropriate proportion of gender diversity in the overall workforce, promote gender balance in management, and ensure that different genders have appropriate representation in the overall workforce (including senior management) to promote diversified decision-making and the optimization of corporate governance. The company will organize diversity training from time to time to improve employees' awareness of the company's diversity policies, encourage a multicultural working environment and promote teamwork.
(3) The company will appropriately disclose the composition of the board of directors (including gender, age, service tenure, etc.), the diversity level of the workforce (including senior management), the summary of this policy, and any measurable goals and progress achieved for the implementation of this policy in the "Corporate Governance Report" included in the annual report.
Article 4 Review and Supervision
The Board of Directors will review and monitor the implementation of this policy from time to time to ensure that this policy is effective.
Article 5 Revision
Any revisions to this policy will need to be recommended by the Nomination Committee of the Board and submitted to the Board for approval.
Board of Directors of Shanghai Pharmaceutical Group Co., Ltd.
November 6, 2025